Wire Screener Dashboard Go Pro

Watchlist

--

--

--

--

Sign in Upgrade Plan Not investment advice. Past performance ≠ future results.

Loading…

Wire Screener Dashboard

Home·Stocks·SNY

SNY

Nasdaq

Sanofi

Basic Materials · Pharmaceutical Preparations

Research view

Fundamentals · SEC EDGAR

Revenue & Earnings — fiscal year

Revenue history unavailable.

Snapshot

SEC EDGAR

Revenue—

Net Income—

Gross Profit—

Oper Income—

EPS (dil)—

Rev/sh—

FCF/sh—

Book/sh—

Gross M—

Oper M—

Profit M—

FCF M—

ROE—

ROA—

ROIC—

R&D/Rev—

Rev Y/Y—

Rev 3Y CAGR—

EPS Y/Y—

EPS 3Y CAGR—

FCF 3Y CAGR—

Payout—

Div/sh—

Shs Chg Y/Y—

Current Ratio—

Quick Ratio—

Debt/Eq—

Int Coverage—

Net Debt—

Total Debt—

Cash & Eq—

Total Assets—

Oper CF—

Capex—

Free CF—

Buybacks—

Equity—

Liabilities—

Shs Outstand—

SectorBasic Materials

🔒 P/E—

🔒 Fwd P/E—

🔒 P/S—

🔒 P/B—

🔒 Market Cap—

🔒 Div Yield—

🔒 52W Range—

🔒 Beta—

40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.

COMMUNITY · $SNY0 theses

POST YOUR TAKE →

Ask AI about SNY Build basket with SNY Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.

SNY Sanofi Stock — fundamentals, financials & AI research · AlgoThesis